Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The second-generation antihistamines. What makes them different?

B T Ryhal1, M P Fletcher

  • 1Department of Internal Medicine, University of California, School of Medicine, Davis.

Postgraduate Medicine
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial.

Annals of the rheumatic diseases·2009
Same author

Effect of infant formula zinc and iron level on zinc absorption, zinc status, and immune function in infant rhesus monkeys.

Journal of pediatric gastroenterology and nutrition·1996
Same author

Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs.

The American journal of physiology·1995
Same author

The toxic oil syndrome: a perspective on immunotoxicological mechanisms.

Regulatory toxicology and pharmacology : RTP·1994
Same author

Limitation of myocardial infarct size in pigs with a dual lipoxygenase-cyclooxygenase blocking agent by inhibition of neutrophil activity without reduction of neutrophil migration.

Journal of the American College of Cardiology·1993
Same author

C5a-induced myocardial ischemia: role for CD18-dependent PMN localization and PMN-platelet interactions.

The American journal of physiology·1993
Same journal

Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

Postgraduate medicine·2026
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
Same journal

Risk of adverse effects of the concomitant use of statins with calcium channel blockers: a systematic review and meta-analysis.

Postgraduate medicine·2026
Same journal

Association between frailty and major chronic disease-free life expectancy: a large community-based longitudinal study.

Postgraduate medicine·2026
See all related articles

Physicians can now better manage drug choices by staying updated on new antihistamine therapies. This review offers valuable insights into the latest advancements in antihistamine treatment options.

Area of Science:

  • Pharmacology
  • Allergy and Immunology

Background:

  • Physicians face challenges balancing drug efficacy with adverse effects.
  • Keeping abreast of novel therapeutic options is crucial for optimal patient care.

Purpose of the Study:

  • To provide an updated overview of current antihistamine therapies.
  • To assist clinicians in navigating the evolving landscape of allergy treatment.

Main Methods:

  • Review of recent scientific literature on antihistamines.
  • Analysis of clinical trial data and pharmacological studies.

Main Results:

  • Emerging antihistamines offer improved efficacy and safety profiles.
  • New formulations and delivery methods enhance patient compliance.

Related Experiment Videos

Conclusions:

  • Staying informed on the latest antihistamine developments aids in clinical decision-making.
  • Optimizing antihistamine selection can improve patient outcomes and reduce side effects.